Effectiveness and cost‐effectiveness of 3‐monthly versus 6‐monthly monitoring of well‐controlled type 2 diabetes patients: a pragmatic randomised controlled patient‐preference equivalence trial in primary care ( <scp>EFFIMODI</scp> study)Paulien R. Wermeling, Guy E.H.M. Rutten, G. Ardine de Wit et al.|Diabetes Obesity and Metabolism|2014Cited by 32
Is zesmaandelijkse controle bij type-2-diabetes haalbaar?Paulien R. Wermeling, Guy E.H.M. Rutten, Kees Gorter et al.|Huisarts en Wetenschap|2015Cited by 0
PS8 - 40. The effect of three- versus six-monthly monitoring on cardiometabolic control in well-controlled type 2 diabetes patients: a pragmatic randomised controlled equivalence trial in primary care (EFFIMODI study)Paulien R. Wermeling, Guy E.H.M. Rutten, Kees Gorter et al.|Nederlands Tijdschrift voor Diabetologie|2012Cited by 0